Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.4800
+0.0100 (2.13%)
Aug 1, 2025, 4:10 PM AEST
Vista Outdoor Revenue
Dimerix had revenue of 287.45K AUD in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 737.87K, up 334.43% year-over-year. In the fiscal year ending June 30, 2024, Dimerix had annual revenue of 583.48K with 1,486.10% growth.
Revenue (ttm)
737.87K
Revenue Growth
+334.43%
P/S Ratio
390.41
Revenue / Employee
n/a
Employees
n/a
Market Cap
288.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 583.48K | 546.69K | 1,486.10% |
| Jun 30, 2023 | 36.79K | -6.43M | -99.43% |
| Jun 30, 2022 | 6.46M | 2.02M | 45.58% |
| Jun 30, 2021 | 4.44M | 2.10M | 89.65% |
| Jun 30, 2020 | 2.34M | 893.56K | 61.74% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
Dimerix News
- 3 months ago - Biotech Dimerix lands $940m licensing deal for kidney drug sales - The Australian Financial Review